Literature DB >> 1127382

Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs.

V A Lennon, J M Lindstrom, M E Seybold.   

Abstract

Immunization of animals with acetylcholine receptor (AChR) protein from the electric organs of Electrophorus electricus and Torpedo californica induces an autoimmune response to the AChR of mammalian skeletal muscle. Rats and guinea pigs develop experimental autoimmune myasthenia gravis (EAMG) after a single inoculation with small quantities of AChR and adjuvant. The indicence and severity of disease appears to depend on the dose of AChR and stability of the emulsion. EAMG is strikingly similar to myasthenia gravis (MG) of man in its clinical picture and its electrophysiological abnormalities. The presence of antibodies to syngeneic rat muscle AChR in the serum of rats with EAMG documents the existence of autoimmunity in the experimental disease. A common immunopathogenesis is suggested for both EAMG and mg.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127382      PMCID: PMC2189842          DOI: 10.1084/jem.141.6.1365

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS.

Authors:  H VAN DER GELD; T E FELTKAMP; J VAN LOGHEM; H J OOSTERHUIS; A BIEMOND
Journal:  Lancet       Date:  1963-08-24       Impact factor: 79.321

2.  Changes in serum complement activity in patients with myasthenia gravis.

Authors:  W L NASTUK; O J PLESCIA; K E OSSERMAN
Journal:  Proc Soc Exp Biol Med       Date:  1960-10

3.  Quantal components of end-plate potentials in the myasthenic syndrome.

Authors:  E H Lambert; D Elmqvist
Journal:  Ann N Y Acad Sci       Date:  1971-09-15       Impact factor: 5.691

4.  Studies on purified eel acetylcholine receptor and anti-acetylcholine receptor antibody.

Authors:  J Patrick; J Lindstrom; B Culp; J McMillan
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

5.  Immunopharmacological disease: a break in tolerance to receptor sites.

Authors:  V A Lennon; P R Carnegie
Journal:  Lancet       Date:  1971-03-27       Impact factor: 79.321

6.  Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.

Authors:  D M Fambrough; D B Drachman; S Satyamurti
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

7.  Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment.

Authors:  M E Seybold; D B Drachman
Journal:  N Engl J Med       Date:  1974-01-10       Impact factor: 91.245

8.  Autoimmune response to acetylcholine receptor.

Authors:  J Patrick; J Lindstrom
Journal:  Science       Date:  1973-05-25       Impact factor: 47.728

9.  Electrical testing in myasthenia gravis.

Authors:  C Ozdemir; R R Young
Journal:  Ann N Y Acad Sci       Date:  1971-09-15       Impact factor: 5.691

10.  Myasthenia gravis in the dog.

Authors:  D C Fraser; A C Palmer; J E Senior; J D Parkes; M F Yealland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-08       Impact factor: 10.154

View more
  72 in total

1.  Experimental study on induction of tolerance to experimental autoimmune myasthenia gravis by immature dendritic cells.

Authors:  Luoqing Li; Shenggang Sun; Xuebing Cao; Yunfu Wang; Liying Chang; Xiaoping Yin
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.

Authors:  Pilar Martínez-Martínez; Mario Losen; Hans Duimel; Peter Frederik; Frank Spaans; Peter Molenaar; Angela Vincent; Marc H De Baets
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 3.  Immunopathologic events at the endplate in myasthenia gravis.

Authors:  T Ashizawa; S H Appel
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses.

Authors:  Xiuhua Yao; Qingfei Kong; Xiaoli Xie; Jinghua Wang; Na Li; Yumei Liu; Bo Sun; Ying Li; Guangyou Wang; Wenjin Li; Siying Qu; Haijun Zhao; Dandan Wang; Xijun Liu; Yao Zhang; Lili Mu; Hulun Li
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

5.  Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis.

Authors:  Chengyong Shen; Yisheng Lu; Bin Zhang; Dwight Figueiredo; Jonathan Bean; Jiung Jung; Haitao Wu; Arnab Barik; Dong-Min Yin; Wen-Cheng Xiong; Lin Mei
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

6.  Experimental autoimmune myasthenia gravis in the mouse.

Authors:  B Wu; E Goluszko; P Christadoss
Journal:  Curr Protoc Immunol       Date:  2001-05

7.  Investigation on the mechanism of exacerbation of myasthenia gravis by aminoglycoside antibiotics in mouse model.

Authors:  Changqin Liu; Fang Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

8.  Effects of the rate of acetylcholine receptor synthesis on the severity of experimental autoimmune myasthenia gravis.

Authors:  M H De Baets; J Verschuuren; M R Daha; P J van Breda Vriesman
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 9.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

10.  Leucocyte migration inhibition in myasthenia gravis. The effect of thymectomy.

Authors:  S Kawanami; Y Itoyama; Y Kuroiwa
Journal:  J Neurol       Date:  1976-07-15       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.